ClinicalTrials.gg
RecruitingNCT06849206Updated Sep 17, 2026

Pennington Generation Cohort

An observational study in Obesity Prevention, sponsored by Pennington Biomedical Research Center. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-09-17.

Primary conditionObesityRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Obesity.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Pennington Biomedical Research Center · Observational

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,000
Sex
All
01

Study summary

The Pennington Generation Cohort is an observational study comprised of Louisiana families. Families will be assessed at baseline for a variety of traits and behaviors, and then followed up over time to try to understand the role of lifestyle and the environment on the risk of developing obesity and other health outcomes.

Read the detailed description

Pennington Biomedical's Greaux Healthy initiative partners with communities to grow healthier generations by expanding the access and reach of Pennington Biomedical's evidence-based practices for the prevention and treatment of childhood obesity. As part of Greaux Healthy, the Pennington Generation Cohort will help evaluate the impact of the program. A sample of up to 1,500 children and adolescents and their families will be recruited from throughout Louisiana. An initial physical exam will establish a baseline for each family with respect to lifestyle behaviors, genetics, and body size/composition. This longitudinal cohort will also assess the association between participation in several childhood obesity prevention and treatment programs and subsequent obesity and related health outcomes. Members of the longitudinal cohort will be followed in the future through clinical visits, questionnaires, and through optional linkages to electronic medical records and administrative databases such as the National Death Index, Social Security Death Master File, and health registry data.

02

Conditions studied

  • Obesity Prevention

Browse trials for

Keywords

  • physical activity
  • obesity
  • diet
  • nutrition
  • families
03

In context

Obesity Reclassified

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 114 across 2,154 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Pennington Biomedical Research Center is the lead sponsor of 284 studies on the registry; 31 are open to participants now.

Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults of child-bearing age who are planning to become pregnant, expectant parents, as well as children, adolescents, and young adults and their nuclear family members will be recruited.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children, adolescents, and young adults (birth through age 24 years) and their nuclear family members* and adults age 25+ who are expectant parents or are trying to conceive
  • Self-reported resident of Louisiana
  • Ability to understand instructions and complete all study procedures
  • Able to provide (adults aged over 18 years)
  • Able to provide assent (children 9 to 17 years)
  • Able to communicate (oral and written) in English

Exclusion criteria

Exclusion Criteria:

  • Discretion of the Medical Monitor or Principal Investigator
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Obesity

    The development of obesity, defined using BMI z-scores during childhood, and BMI during adulthood.

    Time frame: From enrollment up to 20 years of follow-up.

Secondary outcomes

  1. Weight change

    Change in body weight.

    Time frame: From enrollment up to 20 years of follow-up.

  2. Mortality

    Data from the Pennington Generation Prospective Cohort will be prospectively linked to the National Death Index for the ascertainment of mortality.

    Time frame: From enrollment up to 20 years of follow-up..

  3. Cancer incidence

    Data from the Pennington Generation Prospective Cohort will be prospectively linked to the Louisiana Tumor Registry for the ascertainment of incident cancer.

    Time frame: From enrollment up to 20 years of follow-up..

07

Study locations

1 of 1 sites recruiting
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
    Recruiting
    • Peter T Katzmarzyk, PhD · Contactpeter.katzmarzyk@pbrc.edu · 225-763-2536
    • Peter T Katzmarzyk, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — A de-identified individual-level dataset will be made available to researchers making a reasonable request to the principal investigator.

Supporting information: Study protocol

Time frame: Data will be made available 1 year after publication of the primary outcomes manuscript.

Access criteria: Upon reasonable request to the principal investigator and in alignment with the goals of the IRB-approved protocol.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06849206
Responsible party
Peter T. Katzmarzyk (Professor, Pennington Biomedical Research Center) — Principal investigator
First posted
Feb 27, 2025
Start date
Feb 24, 2025
Primary completion
Feb 24, 2045 (estimated)
Completion
Feb 24, 2045 (estimated)
Last update
Sep 17, 2026

Study contacts

Peter T Katzmarzyk, PhD
Contact
peter.katzmarzyk@pbrc.edu
225-763-2536
Kara Denstel, PhD
Contact
kara.denstel@pbrc.edu
763-2614
Peter T Katzmarzyk, PhD
principal investigator · Pennington Biomedical Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion